中国神华AH股逆势走强 拟提高2019–21年度现金分红比例
格隆汇3月30日丨中国神华(1088.HK)现报14.94港元,涨幅4.04%,最新总市值2971.51亿港元;公司A股现报16.83元,涨幅3.44%。公司27日公告称,截至2019年12月31日止年度收入2418.71亿元人民币,同比减少8.4%;归属于公司所有者利润为417.07亿元人民币,同比降5.5%;拟派年度末期股息现金每股人民币1.26元(含税),2018年为0.88元人民币。此外,公司拟提高2019–2021年度的现金分红比例。在符合公司章程规定的情形下,2019–2021年度每年按公司章程规定方式以现金方式分配的利润提高至不少于公司当年实现的归属于公司股东的净利润的50%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.